James Edward Doyle is Director at EXACT SCIENCES CORP (EXAS). They have made 9 open-market trades across 1 company since 2016, most recently 2026-03-23.
CIK 0001614265
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $32K since 2016, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EXAS | 5,398 | $566K |
Shares reported on the most recent Form 4, priced at the 2026-03-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EXAS | SELL · 10b5-1 | 2025-10-09 | 2025-10-10 | $60.00 | $120K | +8.1% | +14.4% | +74.9% |
| EXAS | SELL · 10b5-1 | 2025-08-13 | 2025-08-14 | $42.02 | $125K | +0.8% | +16.8% | +49.5% |
| EXAS | SELL · 10b5-1 | 2024-03-01 | 2024-03-04 | $57.50 | $115K | +0.1% | +24.5% | -23.4% |
| EXAS | SELL · 10b5-1 | 2023-07-27 | 2023-07-28 | $97.42 | $195K | -16.6% | -18.7% | -37.7% |
| EXAS | SELL · 10b5-1 | 2023-06-09 | 2023-06-12 | $90.51 | $254K | +1.7% | +6.6% | -12.4% |
| EXAS | SELL · 10b5-1 | 2023-05-26 | 2023-05-31 | $80.62 | $161K | +11.8% | +15.2% | +2.0% |
| EXAS | SELL | 2021-07-30 | 2021-08-03 | $111.17 | $587K | -10.3% | +4.9% | -5.9% |
| EXAS | SELL | 2021-02-26 | 2021-03-02 | $130.11 | $520K | -5.2% | -2.2% | -20.0% |
| EXAS | SELL | 2020-07-31 | 2020-08-04 | $94.00 | $239K | -7.9% | -17.6% | +31.5% |
| EXAS | SELL | 2020-02-28 | 2020-03-03 | $77.54 | $155K | -25.5% | -22.3% | +15.2% |
| EXAS | SELL | 2019-07-31 | 2019-08-02 | $117.93 | $662K | +6.1% | +6.0% | -21.9% |
| EXAS | SELL | 2019-02-28 | 2019-03-01 | $96.00 | $192K | +2.0% | -2.9% | +9.2% |
| EXAS | SELL | 2018-07-30 | 2018-08-01 | $58.86 | $155K | +2.1% | +55.2% | +33.4% |
| EXAS | SELL | 2018-04-10 | 2018-04-12 | $40.97 | $254K | +2.7% | +13.9% | +36.8% |
| EXAS | BUY | 2016-03-08 | 2016-03-08 | $6.43 | $32K | -1.9% | +13.3% | +16.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.